Status:
RECRUITING
Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Cancer
Exercise
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
MOVE-ONKO is developing and implementing a guideline-based, multi-professional care pathway for the promotion and therapy of exercise for cancer patients. This pathway intended to serve as an interfac...
Eligibility Criteria
Inclusion
- Inclusion Criteria (patients):
- cancer patients during chemotherapy, immune therapy or radiotherapy
- having symptoms/side effects that can be effectively treated by exercise (e.g. fatigue) and/or are interested in exercise oncology counseling
- Inclusion Criteria (care providers)
- \- involved in the implementation process
- Exclusion Criteria (both):
- \- Insufficient German language skills
- Exclusion Criteria (care providers only):
- \- Duration employed \<6 months
Exclusion
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06185777
Start Date
December 1 2023
End Date
October 1 2027
Last Update
February 3 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79106
2
Nationales Centrum für Tumorerkrankungen
Heidelberg, Baden-Wurttemberg, Germany, 69120
3
Medizinische Klinik der Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72076
4
Universitäres Centrum für Tumorekrankungen Frankfurt
Frankfurt am Main, Hesse, Germany, 60488